DataMeds AI's Corexa Health signs supply agreement for six peptides
MEDS•DataMeds AI subsidiary Corexa Health signed an agreement for commercial supply of bulk drug substances for six peptides. Corexa Pharmacy plans to begin dispensing compounded prescriptions for them in November 2026 under HHS' updated enforcement discretion policy.
1. Supply agreement
Corexa Health signed an agreement for commercial supply of bulk drug substances for six peptides. Corexa Pharmacy plans to begin dispensing compounded prescriptions for the peptides in November 2026 under HHS' updated enforcement discretion policy.




